Doctors are skeptical, because they feel this new drug might help kick start the mentality about eating, but are also worried about the idea that no change to dietary or exercise routine is dangerous. The doctors also want to know about the subjects in the study. Pre-human studies with this drug found minuscule change in rodent weight... proportional speaking the doctors believe Saxenda has a real weight loss potential of 7.5 pounds at the 5% significance level. What's the probability of making a Type Il error? Does this hurt the patient more or Saxenda (don't elaborate too much here)?
Doctors are skeptical, because they feel this new drug might help kick start the mentality about eating, but are also worried about the idea that no change to dietary or exercise routine is dangerous. The doctors also want to know about the subjects in the study. Pre-human studies with this drug found minuscule change in rodent weight... proportional speaking the doctors believe Saxenda has a real weight loss potential of 7.5 pounds at the 5% significance level. What's the probability of making a Type Il error? Does this hurt the patient more or Saxenda (don't elaborate too much here)?
MATLAB: An Introduction with Applications
6th Edition
ISBN:9781119256830
Author:Amos Gilat
Publisher:Amos Gilat
Chapter1: Starting With Matlab
Section: Chapter Questions
Problem 1P
Related questions
Topic Video
Question
Answer part D, answers to ABC will be uploaded.
![Step 5
8.776667-10.15
-1.37333
3.KT2983
=137333
0.671934
=-2. 04385
a) The claim is the alternative hypothesis.
b) For the significance,
the degree of freedom is 15-1=14
the t-value is 1-a,n-1 = l0.95,14 = 1. 76131
The p-value for the test statistics is 0.0301.
The p-value says that the data is significant as it is between 0 to 0.04.
We reject the null hypothesis as the test statistics value is less than the critical
value.
Step 6
c)
The type 1 error means that rejecting the null hypothesis when it is true. The
probability of a type l error is the level of significance of the test of hypothesis,
and it is denoted by a.
Here, the null hypothesis is u = 10. 15 and if it is true then the hurt will be to the
Saxenda.](/v2/_next/image?url=https%3A%2F%2Fcontent.bartleby.com%2Fqna-images%2Fquestion%2Fee043644-8c82-4555-bd39-471becdabd6c%2F54638ce7-516c-4135-a5a1-11a8fbf34473%2F15d8uf_processed.png&w=3840&q=75)
Transcribed Image Text:Step 5
8.776667-10.15
-1.37333
3.KT2983
=137333
0.671934
=-2. 04385
a) The claim is the alternative hypothesis.
b) For the significance,
the degree of freedom is 15-1=14
the t-value is 1-a,n-1 = l0.95,14 = 1. 76131
The p-value for the test statistics is 0.0301.
The p-value says that the data is significant as it is between 0 to 0.04.
We reject the null hypothesis as the test statistics value is less than the critical
value.
Step 6
c)
The type 1 error means that rejecting the null hypothesis when it is true. The
probability of a type l error is the level of significance of the test of hypothesis,
and it is denoted by a.
Here, the null hypothesis is u = 10. 15 and if it is true then the hurt will be to the
Saxenda.
![9) More and more weight loss "miracle" drugs have been showing up on the market lately and the FDA has a
challenge to determine what drugs are safe in a variety of different categories. The drugs all target parts of the
brain involved with appetite and satiety, and interfere with hunger signals; so they can reduce the chances that
you'll overeat. All of these drug companies are making huge pushes in the pharmaceutical world for patients to
ask for these prescriptions from their doctors. The makers of a new drug, Saxenda wish to make an injectable
treatment specifically for people with a Body Mass Index (BMI) of at least 30. The makers of Saxenda are making
the claim patients will lose an average of at least 10.15 pounds within one month even with no change in their
dietary or exercise routine. The following data shows the weight loss (in pounds) from volunteers who
participated in some initial medical studies:
4.75 9.98 11.12 10.13 8.7 9.74 12.4 6.4 8.62 7.15 4.8 9.0 12.1 5.2 11.56
a) Create the claims Saxenda is making?
b) Is this data significant? Justify your response!
c) What would a Type I error mean in context? Who would be hurt from this mistake?
d) Doctors are skeptical, because they feel this new drug might help kick start the mentality about eating, but are
also worried about the idea that no change to dietary or exercise routine is dangerous. The doctors also want to
know about the subjects in the study. Pre-human studies with this drug found minuscule change in rodent
weight... proportional speaking the doctors believe Saxenda has a real weight loss potential of 7.5 pounds at the
5% significance level. What's the probability of making a Type Il error? Does this hurt the patient more or
Saxenda (don't elaborate too much here)?](/v2/_next/image?url=https%3A%2F%2Fcontent.bartleby.com%2Fqna-images%2Fquestion%2Fee043644-8c82-4555-bd39-471becdabd6c%2F54638ce7-516c-4135-a5a1-11a8fbf34473%2Fi8i2j3a_processed.jpeg&w=3840&q=75)
Transcribed Image Text:9) More and more weight loss "miracle" drugs have been showing up on the market lately and the FDA has a
challenge to determine what drugs are safe in a variety of different categories. The drugs all target parts of the
brain involved with appetite and satiety, and interfere with hunger signals; so they can reduce the chances that
you'll overeat. All of these drug companies are making huge pushes in the pharmaceutical world for patients to
ask for these prescriptions from their doctors. The makers of a new drug, Saxenda wish to make an injectable
treatment specifically for people with a Body Mass Index (BMI) of at least 30. The makers of Saxenda are making
the claim patients will lose an average of at least 10.15 pounds within one month even with no change in their
dietary or exercise routine. The following data shows the weight loss (in pounds) from volunteers who
participated in some initial medical studies:
4.75 9.98 11.12 10.13 8.7 9.74 12.4 6.4 8.62 7.15 4.8 9.0 12.1 5.2 11.56
a) Create the claims Saxenda is making?
b) Is this data significant? Justify your response!
c) What would a Type I error mean in context? Who would be hurt from this mistake?
d) Doctors are skeptical, because they feel this new drug might help kick start the mentality about eating, but are
also worried about the idea that no change to dietary or exercise routine is dangerous. The doctors also want to
know about the subjects in the study. Pre-human studies with this drug found minuscule change in rodent
weight... proportional speaking the doctors believe Saxenda has a real weight loss potential of 7.5 pounds at the
5% significance level. What's the probability of making a Type Il error? Does this hurt the patient more or
Saxenda (don't elaborate too much here)?
Expert Solution
![](/static/compass_v2/shared-icons/check-mark.png)
This question has been solved!
Explore an expertly crafted, step-by-step solution for a thorough understanding of key concepts.
This is a popular solution!
Trending now
This is a popular solution!
Step by step
Solved in 2 steps
![Blurred answer](/static/compass_v2/solution-images/blurred-answer.jpg)
Knowledge Booster
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, statistics and related others by exploring similar questions and additional content below.Recommended textbooks for you
![MATLAB: An Introduction with Applications](https://www.bartleby.com/isbn_cover_images/9781119256830/9781119256830_smallCoverImage.gif)
MATLAB: An Introduction with Applications
Statistics
ISBN:
9781119256830
Author:
Amos Gilat
Publisher:
John Wiley & Sons Inc
![Probability and Statistics for Engineering and th…](https://www.bartleby.com/isbn_cover_images/9781305251809/9781305251809_smallCoverImage.gif)
Probability and Statistics for Engineering and th…
Statistics
ISBN:
9781305251809
Author:
Jay L. Devore
Publisher:
Cengage Learning
![Statistics for The Behavioral Sciences (MindTap C…](https://www.bartleby.com/isbn_cover_images/9781305504912/9781305504912_smallCoverImage.gif)
Statistics for The Behavioral Sciences (MindTap C…
Statistics
ISBN:
9781305504912
Author:
Frederick J Gravetter, Larry B. Wallnau
Publisher:
Cengage Learning
![MATLAB: An Introduction with Applications](https://www.bartleby.com/isbn_cover_images/9781119256830/9781119256830_smallCoverImage.gif)
MATLAB: An Introduction with Applications
Statistics
ISBN:
9781119256830
Author:
Amos Gilat
Publisher:
John Wiley & Sons Inc
![Probability and Statistics for Engineering and th…](https://www.bartleby.com/isbn_cover_images/9781305251809/9781305251809_smallCoverImage.gif)
Probability and Statistics for Engineering and th…
Statistics
ISBN:
9781305251809
Author:
Jay L. Devore
Publisher:
Cengage Learning
![Statistics for The Behavioral Sciences (MindTap C…](https://www.bartleby.com/isbn_cover_images/9781305504912/9781305504912_smallCoverImage.gif)
Statistics for The Behavioral Sciences (MindTap C…
Statistics
ISBN:
9781305504912
Author:
Frederick J Gravetter, Larry B. Wallnau
Publisher:
Cengage Learning
![Elementary Statistics: Picturing the World (7th E…](https://www.bartleby.com/isbn_cover_images/9780134683416/9780134683416_smallCoverImage.gif)
Elementary Statistics: Picturing the World (7th E…
Statistics
ISBN:
9780134683416
Author:
Ron Larson, Betsy Farber
Publisher:
PEARSON
![The Basic Practice of Statistics](https://www.bartleby.com/isbn_cover_images/9781319042578/9781319042578_smallCoverImage.gif)
The Basic Practice of Statistics
Statistics
ISBN:
9781319042578
Author:
David S. Moore, William I. Notz, Michael A. Fligner
Publisher:
W. H. Freeman
![Introduction to the Practice of Statistics](https://www.bartleby.com/isbn_cover_images/9781319013387/9781319013387_smallCoverImage.gif)
Introduction to the Practice of Statistics
Statistics
ISBN:
9781319013387
Author:
David S. Moore, George P. McCabe, Bruce A. Craig
Publisher:
W. H. Freeman